Singaporean Biotech Startup ImmunoScape Raises US$11M
ImmunoScape is currently collaborating with Arcturus Therapeutics which began human trials of potential COVID-19 vaccine yesterday Singapore-based biotech startup ImmunoScape announced in a press release today that it has raised US$11 million (SG$14.8 million) in an equity financing round led by U.S.-based Anzu Partners, with participation from the University of Tokyo Edge Capital (UTEC) in […]
Singaporean Biotech Startup ImmunoScape Raises US$11M Read More ยป
ImmunoScape is currently collaborating with Arcturus Therapeutics which began human trials of potential COVID-19 vaccine yesterday Singapore-based biotech startup ImmunoScape announced in a press release today that it has raised US$11 million (SG$14.8 million) in an equity financing round led by U.S.-based Anzu Partners, with participation from the University of Tokyo Edge Capital (UTEC) in




